Professor Peter Andrew Eurotherm3235 Trial
The Eurotherm3235Trial is an international, multi-centre, randomised controlled trial which will examine the effects of titrated therapeutic hypothermia (32-35°C) as a treatment for raised intracranial pressure after traumatic brain injury.
Professor Peter Andrew discusses the Eurotherm3235 Trial and his role as Chief Investigator.
Funding provided by:
Aug 2012 - The Eurotherm3235 Trial is funded by the National Institute of Health Research's Health Technology Assessment Programme - www.nihr.ac.uk
The internal pilot was funded by the European Society of Intensive Care Medicine – www.esicm.org
University of Edinburgh and NHS Lothian (UK)